First: Novo Nordisk India launches oral Semaglu...
Novartis' Sandoz dips on debut after lower than...
Novo Nordisk Logo Png
Novo Nordisk Research Centre opens in Oxford | ...
Novo Nordisk
Novo Nordisk receives FDA approval for Wegovy™
Signal: Novo Nordisk market cap higher than Dan...
Is Novo Nordisk Stock a Buy After its Collapse?...
Novo Nordisk submits diabetes pill for US approval
Novo Nordisk’s Global Commitment to Diabetes Ca...
China OKs Novo Nordisk's Type-2 diabetes treatm...
FID prosigue su larga colaboración con Novo Nor...
Novo Nordisk amplía sus fármacos contra la obes...
Novo Nordisk Posts Record Growth as Demand For ...
Novo Nordisk to test anti-obesity molecule in t...
Novo Nordisk's results are stunning - and it co...
Novo Nordisk launches once-a-week diabetes drug...
Novo Nordisk A/S Sees Unusually Large Options V...
NOVO NORDISK INC.: Novo Nordisk Launches Ozempi...
Novo Nordisk hits all-time high as oral obesity...
Novo Nordisk - la compañia que trata la diabete...
Novo Nordisk leaps on new obesity drug data | p...
Novo Nordisk experience big profit rise due to ...